Registry for very small-bodied, low-head-growth syndromes
Part of Genetic & congenital clinical trials.
This is a registry (a secure list of patients) for people with rare conditions that cause very small size and a smaller-than-usual head from early life. It helps researchers learn more about these conditions and how they vary from person to person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A doctor has diagnosed you with a rare “primordial dwarfism” condition or a closely related syndrome
- Your condition affects head size (microcephaly) along with very small body growth
- You can be confirmed as having microcephalic primordial dwarfism or a related condition
- You do not have to meet additional study treatments, since this is a registry
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a patient registry that collects health information from people with fibrous dysplasia, McCune-Albright syndrome, or Mazabraud’s syndrome. It helps researchers understand these conditions better and may support future studies.
This study keeps a registry (a structured list) of people with rare diseases and may also track how the condition changes over time. It can help researchers better understand rare illnesses and find gaps in care, which may improve future treatments.
This is a research registry that enrolls people with achondroplasia or hypochondroplasia. It helps researchers collect information about the condition to improve understanding and future studies.
This study is for people who have a rare syndrome or rare congenital condition and are seen at a rare-disease clinic. It aims to better understand these conditions and how care works in a team setting, which may help guide future treatment decisions.
This study is a registry that collects information about people with multiple osteochondromas (extra bone/cartilage growths). It may help researchers better understand the condition and improve future care, even if no treatment is given.
This trial is a registry, which means it collects information about people with Ollier disease and Maffucci syndrome. It can help researchers better understand these conditions and plan future studies.
Hear when a new MOPDII trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.